Synthetic cannabinoids

Designer drugs

Nº Q19904200 ★★★

Rare · Savoirs

Synthetic cannabinoids

Designer drugs

Texte en anglais

Synthetic cannabinoids, or neocannabinoids, are a class of designer drug molecules that bind to the same receptors to which cannabinoids (e.g THC, CBD and CBN) in cannabis plants attach. These novel psychoactive substances should not be confused with synthetic phytocannabinoids (obtained by chemical synthesis) or synthetic endocannabinoids from which they are distinct in many aspects.

Dernier prix

—

Prix plancher

—

Médiane 7 j

—

Ventes 30 j

0

Fourchette 30 j

—

En circulation

0

Cours

Voir le tableau
Datemédiane MinMaxventes

Historique des ventes

Dernière vente
—
Moyenne 30 j
—
Plus bas 30 j
—
Plus haut 30 j
—
Ventes 7 j
0
Ventes 30 j
0

Aucune vente pour l'instant.

Ventes anonymes : ni acheteur ni vendeur. Les chiffres ne comptent que les ventes entre joueurs.

№ Éditions numérotées · 0 frappées Prochain n° 1 · Score ×3
Sur Wikipédia

Texte en anglais Pas encore d'article dans ta langue : extrait en anglais.

Synthetic cannabinoids, or neocannabinoids, are a class of designer drug molecules that bind to the same receptors to which cannabinoids (e.g THC, CBD and CBN) in cannabis plants attach. These novel psychoactive substances should not be confused with synthetic phytocannabinoids (obtained by chemical synthesis) or synthetic endocannabinoids from which they are distinct in many aspects. Typically, synthetic cannabinoids are sprayed onto plant matter and are usually smoked, although they have also been ingested as a concentrated liquid form in the United States and United Kingdom since 2016. They have been marketed as herbal incense, or "herbal smoking blends", and sold under common names such as K2, Five Spice, spice, and synthetic marijuana. They are often labeled "not for human consumption" to support a liability legal defense. A large and complex variety of synthetic cannabinoids are designed in an attempt to avoid legal restrictions on cannabis, making synthetic cannabinoids designer drugs. Most synthetic cannabinoids are agonists of the cannabinoid receptors. They have been designed to be similar to THC, the natural cannabinoid with the strongest binding affinity to the CB1 receptor, which is linked to the psychoactive effects or "high" of marijuana. These synthetic analogs often have greater binding affinity and greater potency to the CB1 receptors. There are several synthetic cannabinoid families (e.g., AM-xxx, CP-xx,xxx, HU-xx, JWH-xxx) which are classified by the creator of the substance (e.g., JWH stands for John W. Huffman), which can include several substances with different base structures such as classical cannabinoids and unrelated naphthoylindoles. Synthetic marijuana compounds began to be manufactured and sold in the early 2000s. From 2008 to 2014, 142 synthetic cannabinoid receptor agonists were reported to the European Monitoring-Center for Drugs and Drug Addiction (EMCDDA). Reported user negative effects include palpitations, paranoia, intense anxiety, nausea, vomiting, confusion, poor coordination, and seizures. There...

Texte : Wikipédia en anglais, CC BY-SA 4.0. · Image : Legal order synthetic smoke (Public domain) ·

Cartes voisines

Confirmation